Patient Access to Lab Services

Coinsurance would disrupt the ability of health care practitioners to work with their patients to ascertain the best lab tests to help best diagnose new conditions, manage existing conditions, and guide therapy, which is critical for the Medicare population as they often have multiple comorbidities. Currently, since there is no cost-sharing, patients who need more…

Coinsurance would disrupt the ability of health care practitioners to work with their patients to ascertain the best lab tests to help best diagnose new conditions, manage existing conditions, and guide therapy, which is critical for the Medicare population as they often have multiple comorbidities. Currently, since there is no cost-sharing, patients who need more lab tests due to more complicated health conditions have no greater financial risk than patients those with less complex conditions when receiving their lab results – and a patient may not know whether their condition is simple or complex when they first see a doctor. Despite this common-sense approach, some policy-makers calling for entitlement reform and deficit reduction have proposed putting into place a new 20% patient coinsurance for clinical laboratory services as an attempt to make Medicare beneficiaries more aware of health care costs. In real life, coinsurance for lab services will dis-incentivize Medicare beneficiaries from receiving timely and life-saving clinical lab tests, thus increasing health care costs through worse outcomes, and would drastically increase the cost of providing lab services through generating millions of new patient bills.

Read More

  • ACLA and G2 Intelligence Hold Webinar On CMS Rule Allowing Patients’ Direct Access to Lab Results

    March 20, 2014
    WASHINGTON, D.C. –  In order to provide perspective and impact analysis for clinical laboratory professionals regarding a recently announced rule by the Centers for Medicare and Medicaid Services (CMS) that would allow consumers direct access to their lab results, the American Clinical Laboratory Association (ACLA) and G2 Intelligence, an organization reporting on the diagnostic industry for more than 30 years, will sponsor a webinarContinue Reading »...
  • Innovation must be part of the cost evaluation of healthcare

    March 11, 2014
    Arguments can be made on both sides about access and quality, when comparing our healthcare system to the rest of the industrialized world. But, few would dispute that American healthcare is the most innovative in the world. In fact, the creativity and expertise of American manufacturers, doctors, hospitals and Academic Medical Centers, laboratories, drug companies, health IT companies, and other participants set the standardContinue Reading »...
  • Pay cuts could wipe out labs, hurt nursing homes

    February 05, 2014
    When it comes to worries about how Medicare doctors will be paid, nursing home operators have thought they should stand at the front of a long and anxious line. Truth be told, they have some stiff competition for the “most nervous” title. That might go to the clinical lab folks. Although many provider groups are worried about which will have to sacrifice the mostContinue Reading »...
  • A Statement from the American Clinical Laboratory Association (ACLA) on the HHS-CMS Final Rule Allowing Patients Direct Access to Personal Laboratory Results

    February 04, 2014
    On behalf of ACLA — a not-for-profit association representing the nation’s leading national and regional clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies – ACLA President Alan Mertz issued the following statement: The ACLA today expressed its support for a new regulation issued by the Department of Health and Human Services (HHS), to be released inContinue Reading »...
  • Letter to Chairman Baucus and Ranking Member Hatch Regarding Coinsurance

    March 01, 2013
      March 1, 2013 The Honorable Max Baucus Chairman, Committee on Finance U.S. Senate 219 Dirksen Senate Office Building Washington, DC 20510 The Honorable Orrin Hatch Ranking Member, Committee on Finance U.S. Senate 219 Dirksen Senate Office Building Washington, DC 20510 Dear Chairman Baucus and Ranking Member Hatch: We, the undersigned, applaud your leadership in strengthening the Medicare program for current and future beneficiaries.Continue Reading »...
  • Letter to Joint Deficit Committee Members Regarding Coinsurance

    August 25, 2011
      August 25, 2011 The Honorable Fred Upton Chairman, House Energy and Commerce Committee 2183 Rayburn House Office Building United States House of Representatives Washington, DC 20515 Dear Representative Upton: I am writing you today on behalf of the American Clinical Laboratory Association (ACLA), which represents the leading national, regional, esoteric, pathology and ESRD clinical laboratories. As a member of the Joint Select CommitteeContinue Reading »...
  • Joint Deficit Committee Urged to Reject Laboratory Cost Sharing

    August 25, 2011
    For Release: August 25, 2011 Contact: Alan Mertz, President, ACLA; 202-637-9466 Joint Deficit Committee Urged to Reject Laboratory Cost Sharing Collecting the fees could cost more than the income received and harm access for beneficiaries says American Clinical Laboratory Association Asking Medicare beneficiaries to pay as much as 20% of the cost of their laboratory tests could cost more than it saves, force manyContinue Reading »...
  • Letter to Senators Reid and McConnell, Representatives Boehner and Pelosi Regarding Coalition Letter Against Medicare Coinsurance for Lab Services

    July 11, 2011
      Dear Majority Leader Reid, Minority Leader McConnell, Speaker Boehner, and Minority Leader Pelosi: We, the undersigned organizations, represent the interests of a broad cross-section of our nation’s Medicare beneficiaries as well as the health care providers who care for them. While we believe it is critically important for our nation’s fiscal health to address the deficit, we are deeply concerned by a numberContinue Reading »...
  • Letter to Congress from Patient and Senior Groups on Lab Coinsurance

    July 11, 2011
      Dear Majority Leader Reid, Minority Leader McConnell, Speaker Boehner, and Minority Leader Pelosi: We, the undersigned organizations, represent the interests of a broad cross-section of our nation’s Medicare beneficiaries as well as the health care providers who care for them. While we believe it is critically important for our nation’s fiscal health to address the deficit, we are deeply concerned by a numberContinue Reading »...
  • Letter to Senators Reid and McConnell Regarding Coinsurance

    July 07, 2011
      The Honorable Harry Reid Majority Leader U.S. Senate 522 Hart Senate Office Building Washington, DC 20510 The Honorable Mitch McConnell Minority Leader U.S. Senate 317 Russell Senate Office Building Washington, DC 20510 Dear Majority Leader Reid and Minority Leader McConnell: The undersigned laboratory and health care organizations, representing America’s community, regional, and national laboratories, their employees, practitioners, and the Medicare patients we serveContinue Reading »...
1 2 3 4